The following information is limited to United Therapeutics sponsored studies. Information is not intended to offer recommendations for any administration, indication, dosage, or other use inconsistent with approved prescribing information.




Advances in Neuroblastoma Research 2018

AMCP Annual Meeting 2018

AMCP Nexus 2018

American Association for Cancer Research 2019

ASCO Annual Meeting 2018

ATS International Conference 2018 - 2019

CHEST Annual Meeting 2018

European Lung Cancer Congress 2018

ISHLT Annual Meeting & Scientific Sessions 2019

ISPOR Conference 2018

PVRI Annual World Congress of PVD 2019

UT Product


Orenitram® (treprostinil) Extended-Release Tablets

Remodulin® (treprostinil) Injection

Tyvaso® (treprostinil) Inhalation Solution

Unituxin® (dinutuximab) Injection